Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

VEGF blockade enhances the antitumor effect of BRAFV600E inhibition

ABSTRACT: This SuperSeries is composed of the SubSeries listed below.

ORGANISM(S): Mus musculus Homo sapiens

PROVIDER: GSE69754 | GEO | 2016/12/19

SECONDARY ACCESSION(S): PRJNA286655

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Similar Datasets

VEGF blockade enhances the antitumor effect of BRAFV600E inhibition.

Project description: Not available

| S-EPMC5286370 | biostudies-literature

VEGF blockade enhances the antitumor effect of BRAFV600E inhibition (mouse)

Project description:In this work we investigated the combined effects of the BRAF inhibition and of the VEGF blockade in a preclinical model of melanoma. The purpose of this dataset was to examine the transcriptional responses of a A375 xenograft model to PLX472 and bevacizumab, either as single agents or as combination therapy. We performed species-specific analysis of gene expression to discriminate the effects of the different therapeutic regimens on tumor cells (human) and stromal microenvironment (mouse). Here, Illumina Mouse BeadChips were used to profile the transcriptome after 12 days treatment. We reported that dispensing the dual treatment is more efficient than the single compounds and the occurrence of resistance by modifying the tumor genetic programs regulating myeloid cells recruitment and extracellular matrix remodeling.

2016-12-19 | GSE69744 | GEO

VEGF blockade enhances the antitumor effect of BRAFV600E inhibition (human)

Project description:In this work we investigated the combined effects of the BRAF inhibition and of the VEGF blockade in a preclinical model of melanoma. The purpose of this dataset was to examine the transcriptional responses of a A375 xenograft model to PLX472 and bevacizumab, either as single agents or as combination therapy. We performed species-specific analysis of gene expression to discriminate the effects of the different therapeutic regimens on tumor cells (human) and stromal microenvironment (mouse). Here, Illumina Human BeadChips were used to profile the transcriptome after 12 days treatment. We reported that dispensing the dual treatment is more efficient than the single compounds and the occurrence of resistance by modifying the tumor genetic programs regulating myeloid cells recruitment and extracellular matrix remodeling.

2016-12-19 | GSE69742 | GEO

Effect of lymphotoxin beta receptor blockade on microRNA expression in the spleen

Project description:This SuperSeries is composed of the SubSeries listed below. Refer to individual Series

2014-06-20 | E-GEOD-55722 | biostudies-arrayexpress

Dnase1l3 enhances antitumor immunity and suppresses tumor progression

Project description:This SuperSeries is composed of the SubSeries listed below.

2022-02-07 | GSE196077 | GEO

Blocking TWEAK inhibits tumor growth through inhibition of tumor cell proliferation and survival and by enhancing the host antitumor immune response

Project description:This SuperSeries is composed of the SubSeries listed below. Refer to individual Series

2013-09-30 | E-GEOD-42050 | biostudies-arrayexpress

VEGF-B in rat hearts

Project description:This SuperSeries is composed of the SubSeries listed below. Refer to individual Series

2013-11-30 | E-GEOD-38457 | biostudies-arrayexpress

Phototherapy restores deficient type I interferon production and enhances antitumor responses in mycosis fungoides

Project description:This SuperSeries is composed of the SubSeries listed below.

2023-06-14 | GSE234856 | GEO

BET Inhibition Enhances TNF Mediated Anti-Tumor Immunity

Project description:This SuperSeries is composed of the SubSeries listed below.

2021-09-24 | GSE184592 | GEO

A selective HDAC8 inhibitor potentiates antitumor immunity and efficacy of immune checkpoint blockade in hepatocellular carcinoma

Project description:This SuperSeries is composed of the SubSeries listed below.

2021-04-04 | GSE164444 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data